Search results: International
Report Cards
This project is investigating whether targeting a particular protein called TRIM24 could serve as a potential therapy for men with castrate resistant prostate cancer. The funded work will be conducted using pre-clinical models has implications for drug development, and if successful could lead to the initiation of clinical trials for men with advanced prostate cancer.
To research and define the in vitro benefit of heart glycosides and similar substances combined with standard prostate cancer pharmaceuticals such as cytotoxic drugs in the advanced stages of prostate cancer.